GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (OTCPK:MKEAF) » Definitions » Cash, Cash Equivalents, Marketable Securities

Mauna Kea Technologies (Mauna Kea Technologies) Cash, Cash Equivalents, Marketable Securities : $8.62 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Mauna Kea Technologies Cash, Cash Equivalents, Marketable Securities?

Mauna Kea Technologies's quarterly cash, cash equivalents, marketable securities increased from Dec. 2022 ($3.33 Mil) to Jun. 2023 ($6.84 Mil) and increased from Jun. 2023 ($6.84 Mil) to Dec. 2023 ($8.62 Mil).

Mauna Kea Technologies's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($13.44 Mil) to Dec. 2022 ($3.33 Mil) but then increased from Dec. 2022 ($3.33 Mil) to Dec. 2023 ($8.62 Mil).


Mauna Kea Technologies Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Mauna Kea Technologies's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Cash, Cash Equivalents, Marketable Securities Chart

Mauna Kea Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.16 10.54 13.44 3.33 8.62

Mauna Kea Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.44 5.64 3.33 6.84 8.62

Mauna Kea Technologies Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Mauna Kea Technologies  (OTCPK:MKEAF) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Mauna Kea Technologies Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Mauna Kea Technologies (Mauna Kea Technologies) Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (Mauna Kea Technologies) Headlines